Susan Bronskill

PhD
Associate Scientist
susan.bronskill@ices.on.ca
Phone: 437-317-8878

Research Assistant:

Danielle Vassallo
Email: danielle.vassallo@ices.on.ca

Dr. Bronskill is a national expert in health services research using administrative databases with a focus on older adults, pharmacoepidemiology and neurodegenerative disease. In collaboration with policymakers and health system partners, she studies transitions between health care sectors and focusses on improving quality of care, medication use, health services utilization and health care outcomes — in particular dementia from Alzheimer’s disease or other causes.

Education

  • B.Sc., 1993, Economics, University of Toronto,
  • M.Sc., 1996, Health Administration, University of Toronto,
  • PhD, 2001, Health Policy, Harvard University,

Appointments & Affiliations

  • Scientist, Evaluative Clinical Sciences, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute,
  • Senior Scientist & Scientific Lead, Life Stage Research Program, ICES (formerly Institute for Clinical Evaluative Sciences),
  • Professor, Institute of Health Policy, Management & Evaluation, Dalla Lana School of Public Health, University of Toronto,

Research Foci

  • Health services research
  • Pharmacoepidemiology
  • Quality of care for older adults

Publications

Affiliated Labs & Programs

Selected Publications

  1. Jones A, Maclagan LC, Watt JA, Schull MJ, Jaakkimainen L, Swayze S, Guan J, Bronskill SE. Reasons for repeated emergency department visits among community-dwelling older adults with dementia in Ontario, Canada. J Am Ger Soc, 2022 Jun;70(6):1745-1753.

  2. Bronskill SE, Maclagan LC, Maxwell CJ, Iaboni A, Jaakkimainen RL, Marras C, Wang X, Guan J, Harris DA, Emdin A, Jones A, Sourial N, Godard-Sebillotte C, Vedel I, Austin PC, Swartz RH. Trends in health service use for Canadian adults with dementia and Parkinson disease during the first wave of the COVID-19 pandemic. JAMA Health Forum, 2022 Jan 21;3(1):e214599.

  3. Harris DA, Maclagan LC, Iaboni A, Austin PC, Rosella LC, Maxwell CJ, Campitelli M, Pequeno P, Guan J, Kirkham J, Bronskill SE. Potential unintended consequences of antipsychotic reduction in Ontario nursing homes. JAMDA, 2022 Jun;23(6):1066-1072.e7.

  4. Bronskill SE, Campitelli MA, Iaboni A, Herrmann N, Guan J, Maclagan LC, Watt J, Rochon PA, Morris AM, Jeffs L, Bell CM, Maxwell CJ. Low-dose trazodone, benzodiazepines & fall-related injuries in nursing homes: a matched cohort study. J Am Geriatr Soc 2018 Sep 24;66(10):1963-1971.